Citius Oncology, Inc. Cash Flow Statement

Cash Flow Statement Sep2024 Sep2025
Operating Activities
Net Income -21.15M-24.76M
Share-based Compensation 7.50M8.32M
Deferred Taxes 0.58M1.06M
Cash from Operations 0.13M-5.49M
Change in Working Capital
Change in Inventory 2.13M12.65M
Change in Account Payables 14.27M9.52M
Change in Accured Expenses -0.26M4.09M
Other Working Capital Changes 1.10M
Investing Activities
Change in Intangibles 5.00M5.75M
Cash from Investing Activities -5.00M-5.75M
Financing Activities
Cash from Financing Activities 4.87M15.17M
Additional items
Change in Cash 112.003.92M
Beginning Cash Balance -112.00-3.92M
Free Cash Flow 0.13M-5.49M
Net Cash Flow 112.003.92M